Table 2 Ten most frequent cancers in black South African men and women by HIV status (2004 – 2009)
HIV positive men (n = 596) | HIV negative men (n = 1197) | ||
|---|---|---|---|
Kaposi sarcoma | 260 (43.6) | Lip, oral cavity and pharynx | 216 (18.1) |
NHL | 94 (15.8) | Lung | 167 (14.0) |
    Diffuse large B cell lymphoma | 54 (9.1) |  |  |
    Burkitt’s lymphoma | 6 (1.0) | ||
    Other NHL | 34 (5.7) | ||
Lip, oral cavity and pharynx | 38 (6.4) | Oesophagus | 125 (10.4) |
Lung | 34 (5.7) | Nasal cavity and larynx | 82 (6.9) |
Nasal cavity and larynx | 21 (3.5) | Stomach | 54 (4.5) |
Oesophagus | 19 (3.2) | Colon | 45 (3.8) |
Hodgkin Lymphoma | 15 (2.5) | Anorectal | 45 (3.8) |
Liver | 11 (1.9) | Liver | 45 (3.8) |
Stomach | 9 (1.5) | Pancreas | 39 (3.3) |
Skin (non-melanoma, non-SCC*) | 7 (1.2) | Prostate | 39 (3.3) |
HIV positive women (n = 1237) | HIV negative women (n = 2406) | ||
Cervix | 448 (36.2) | Breast | 874 (36.3) |
Breast | 241 (19.5) | Cervix | 718 (29.8) |
Kaposi sarcoma | 226 (18.3) | Oesophagus | 93 (3.9) |
NHL | 95 (7.7) | Ovary | 89 (3.7) |
    Diffuse large B cell lymphoma | 61 (4.9) |  |  |
    Burkitt’s lymphoma | 9 (0.7) | ||
    Other NHL | 25 (2.0) | ||
Lip, oral cavity and pharynx | 26 (2.1) | Uterus | 84 (3.5) |
Vulva | 22 (1.8) | Colon | 54 (2.2) |
Uterus | 17 (1.4) | Lip, oral cavity and pharynx | 51 (2.1) |
Conjunctiva, Eye | 17 (1.4) | Lung | 48 (2.0) |
Lung | 15 (1.2) | Anorectal | 39 (1.6) |
Oesophagus | 14 (1.1) | NHL | 30 (1.3) |
|  |  |     Diffuse large B cell lymphoma | 10 (0.4) |
    Burkitt’s lymphoma | 2 (0.1) | ||
    Other NHL | 18 (0.8) | ||